The p53 tumor-suppressor gene

New England Journal of Medicine

Volumn 326, Issue 20, 1992, Pages 1350-1352

  Levine, Arnold J ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CANCER RISK; CARCINOGENESIS; CELL GROWTH; DISEASE PREDISPOSITION; EDITORIAL; FAMILIAL CANCER; GENE EXPRESSION REGULATION; GENE MUTATION; GERM CELL; HUMAN; NONHUMAN; NONSENSE MUTATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN MODIFICATION; SARCOMA; SOMATIC CELL; TUMOR SUPPRESSOR GENE;

EID: 0026561245     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199205143262008     Document Type: Editorial

References (14)

1. Brugge J., Curran T., Harlow E., McCormick F., eds. The origins of human cancers: a comprehensive review. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 1991.
2. Tumour suppressor genes, the cell cycle and cancer. Cancer Surv 1992; 12.
3. Knudson A.G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68:820-823
4. Cavenee W.K., Dryja T.P., Phillips R.A., et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983; 305:779-784
5. Levine A.J., Momand J., Finlay C.A. The p53 tumour suppressor gene. Nature 1991; 351:453-456
6. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 Mutations in human cancers. Science 1991; 253:49-53.
7. Malkin D., Li F.P., Strong L.C., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250:1233-1238
8. Srivastava S., Zou Z.Q., Pirollo K., Blattner W.A., Chang E.H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990; 348:747-749
9. Malkin D., Jolly K.W., Barbier N., et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 1992; 326:1309-1315
10. Toguchida J., Yamaguchi T., Dayton S.H., et al. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 1992; 326:1301-1308
11. Martinez J., Georgoff I., Martinez J., Levine A.J. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 1991; 5:151-159
12. Miller C.W., Asio A., Tsay C., et al. Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 1990; 50:7950-7954
13. Donehower L.A., Harvey M., Slagle B.L., et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215-221
14. Lavigueur A., Maltby V., Mock D., Rossant J., Pawson T., Bernstein A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 1989; 9:3982-3991